Document Detail

Forskolin enhances calcium-evoked prolactin release from 7315c tumor cells without increasing the cytosolic calcium concentration.
MedLine Citation:
PMID:  3010075     Owner:  NLM     Status:  MEDLINE    
The 7315c prolactin-secreting tumor cell was used as a model of a normal pituitary cell in order to study the enhancement by adenosine 3',5'-cyclic monophosphate (cAMP) of calcium-evoked hormone release. Forskolin and, by implication, cAMP had little effect on basal hormone release during a 10-min incubation period. Ionomycin and a high potassium concentration, treatments which enhanced the cytosolic calcium concentration, increased hormone release. When cells were exposed to forskolin prior to and during a challenge with either ionomycin or high potassium, a synergistic effect on prolactin release was observed. 8-Bromoadenosine 3',5'-cyclic monophosphate mimicked forskolin in enhancing ionomycin-evoked prolactin release while having little effect of its own on hormone release. Forskolin did not alter the increase in cytosolic calcium concentration elicited by either ionomycin or high potassium, nor did it increase the potency of ionomycin in enhancing prolactin release. The calcium channel antagonist, D-600, did not alter ionomycin-induced release or its enhancement by forskolin; D-600 blocked potassium-induced prolactin release. Ionomycin had no effect on basal cAMP synthesis by tumor cells and inhibited slightly the forskolin-induced increase in nucleotide synthesis. The results suggest that cAMP acts, at a site distal to the entry of calcium into the cytosol, to enhance the amount of prolactin released in response to an increase in the cytosolic calcium concentration.
E A Frey; J W Kebabian; S Guild
Related Documents :
23695875 - The effect of acute hypoxia on short-circuit current and epithelial resistivity in biop...
3100385 - In vitro study of frog (rana ridibunda pallas) neurointermediate lobe secretion by use ...
7588325 - In vitro characterization of four novel classes of growth hormone-releasing peptide.
21595605 - Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to...
11325725 - A single residue differentiates between human cardiac and skeletal muscle na+ channel s...
16003705 - Inhibition of the reverse mode of the na+/ca2+ exchange by kb-r7943 augments arrhythmog...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular pharmacology     Volume:  29     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  1986 May 
Date Detail:
Created Date:  1986-06-23     Completed Date:  1986-06-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  461-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
8-Bromo Cyclic Adenosine Monophosphate / pharmacology
Aminoquinolines / diagnostic use
Calcium / analysis*,  physiology
Cell Line
Cyclic AMP / biosynthesis
Cytosol / analysis*
Ethers / pharmacology
Forskolin / pharmacology*
Pituitary Neoplasms / secretion*
Potassium / pharmacology
Prolactin / immunology,  secretion*
Reg. No./Substance:
0/Aminoquinolines; 0/Ethers; 23583-48-4/8-Bromo Cyclic Adenosine Monophosphate; 56092-81-0/Ionomycin; 60-92-4/Cyclic AMP; 66428-89-5/Forskolin; 7440-09-7/Potassium; 7440-70-2/Calcium; 83014-44-2/Quin2; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Next Document:  Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat...